Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Latest news

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Novo Nordisk Partners With South Africa-Based Aspen To Supply Insulin For African Countries

By Vandana Singh
September 19, 9:24 AM
Novo Nordisk A/S (NYSE: NVO) announced a new partnership with&

NVO

Read More
1 minute read
  • Biotech
  • General
  • News

Immix Biopharma Subsidiary Nexcella Completes 2nd NXC-201 Engineering Batch At Its U.S. CAR-T Manufacturing Site

By Benzinga Newsdesk
September 19, 9:23 AM
Successful completion supports expansion of its ongoing NEXICART-1 (NCT04720313) NXC-201 CAR-T clinical trial to the U.S.Plan for NXC-201 to expand into earlier lines of therapy, and beyond the 5% of U.S. hospitals that

IMMX

Read More
3 minute read
  • News

AMD Accelerates Innovation At The Edge With Kria K24 SOM And Starter Kit For Industrial And Commercial Applications

By Benzinga Newsdesk
September 19, 9:22 AM
— K24 SOM and KD240 Kit enable the design of power-efficient, production-ready solutions for motor control and digital signal processing applications with a fast time to market —SANTA CLARA, Calif., Sept. 19, 2023 (GLOBE

AMD

Read More
1 minute read
  • Earnings
  • Equities
  • Guidance
  • Markets
  • Movers
  • News
  • Tech

Why Endava Shares Are Slipping Today

By Anusuya Lahiri
September 19, 9:21 AM
Digital transformation, agile development, and intelligent automation services provider Endava Plc (NYSE: DAVA) reported fourth-quarter FY23 revenue growth of 5.2% year-on-year to £189.8 million ($237.52 million), beating the 

DAVA

Read More
1 minute read
  • Contracts
  • News

CPS Technologies Receives Received A Phase I SBIR Award, Valued At ~$200,000, From The U.S. Department Of Energy

By Benzinga Newsdesk
September 19, 9:21 AM
CPS Technologies Corporation (NASDAQ:CPSH) ("CPS" or the "Company") today announced that it has received a phase I SBIR award, valued at approximately $200,000, from the U.S. Department of Energy, its first such grant

CPSH

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News

European Commission Approves GSK/Pfizer-Backed HIV Infection Prevention Drug

By Vandana Singh
September 19, 9:20 AM
The European Commission has approved ViiV Healthcare's Apretude (cabotegravir long-acting (LA) injectable and tablets) 

GSK

Read More
2 minute read
  • Guidance
  • News

Vital Farms Updates Long-Term Financial Targets; Company Sets $1B Net Revenue Target For 2027; Maintains 2023 Net Revenue And Adjusted EBITDA Forecast

By Benzinga Newsdesk
September 19, 9:20 AM
Vital Farms (NASDAQ:VITL), a Certified B Corporation that offers a range of ethically produced foods nationwide, today updated its long-term financial targets and plans to provide additional detail at its Analyst Day

VITL

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • Movers
  • News

Chinese Drugmaker BeiGene And Novartis Move Out From Second Cancer Drug Pact

By Vandana Singh
September 19, 9:18 AM
BeiGene Ltd (NASDAQ: BGNE) said it would regain rights to develop, manufacture, and commercialize Tevimbra (tislelizumab), its cancer drug, from Novartis AG (NYSE: NVS).

BGNE

Read More
4 minute read
  • News

Zepp Health Launches New Line Of Over The Counter Hearing Aids For Its Zepp Clarity Brand

By Benzinga Newsdesk
September 19, 9:18 AM
Zepp Clarity Pixie Elevates the Listening Experience, Built on the Success of Zepp Clarity OneZepp Clarity, a smart hearing solutions brand owned by Zepp Health (NYSE:ZEPP), a health technology company, todaydebuted its

ZEPP

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Safe Harbor Launches New Line Of Credit Products For Cannabis Businesses

By Nina Zdinjak
September 19, 9:18 AM
SHF Holdings, Inc., doing business as Safe Harbor Financial (NASDAQ: SHFS), a facilitator of financial services and credit solutions for the cannabis industry is launching a new portfolio of line of credit products available to cannabis businesses nati

SHFS

Posts pagination

Previous 1 … 6,759 6,760 6,761 … 19,074 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service